Wednesday, March 26, 2014

Bulk Drug Substances That May Be Used to Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Request for Nominations--Letters Posted so Far for Public Viewing

null
  • See Attached
  • Public Submission
  • Posted:
    03/07/2014
  • ID:
    FDA-2013-N-1525-0002
  • Organization:
  • Submitter Name:


null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Carbonyl Iron for...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0004
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Acetyl-D Glucosamine...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0010
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Aloe Vera 200:1...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0011
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Chlorella for...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0005
  • Organization:
  • Submitter Name:

null
  • See Attached
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0007
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Beta Glucan (1,3/1,4...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0014
  • Organization:
  • Submitter Name:

null
  • See Attached
  • Public Submission
  • Posted:
    03/10/2014
  • ID:
    FDA-2013-N-1525-0003
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Ashwagandha Extract 2...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0012
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate 7-Keto...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0006
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate Astragalus Extract 10...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0013
  • Organization:
  • Submitter Name:

null
  • See Attached
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0008
  • Organization:
  • Submitter Name:

null
  • Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Rm. 1061 Rockville, MD 20852 Dear Sir or Madam, We hereby nominate the drugs listed below...
  • Public Submission
  • Posted:
    03/20/2014
  • ID:
    FDA-2013-N-1525-0009

No comments: